166 related articles for article (PubMed ID: 38698266)
1. CRL2
Motomura S; Yumimoto K; Tomonaga T; Nakayama KI
Oncogene; 2024 May; ():. PubMed ID: 38698266
[TBL] [Abstract][Full Text] [Related]
2. CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14
Zhang P; Gao K; Zhang L; Sun H; Zhao X; Liu Y; Lv Z; Shi Q; Chen Y; Jiao D; Li Y; Gu W; Wang C
Cell Death Differ; 2022 Apr; 29(4):758-771. PubMed ID: 34743205
[TBL] [Abstract][Full Text] [Related]
3. An intrinsic network of polar interactions is responsible for binding of UL49.5 C-degron by the CRL2
Ślusarz MJ; Lipińska AD
Proteins; 2024 May; 92(5):610-622. PubMed ID: 38069558
[TBL] [Abstract][Full Text] [Related]
4. CRL2
Liu Y; Luo Y; Yan S; Lian YF; Wu S; Xu M; Feng L; Zhang X; Li R; Zhang X; Feng QS; Zeng YX; Zhang H
Oncogene; 2022 May; 41(22):3104-3117. PubMed ID: 35468939
[TBL] [Abstract][Full Text] [Related]
5. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
[TBL] [Abstract][Full Text] [Related]
6. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
Guo Z; Zhou Y; Evers BM; Wang Q
Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
[TBL] [Abstract][Full Text] [Related]
7. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
8. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
Koo J; Wu X; Mao Z; Khuri FR; Sun SY
J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
10. E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc.
Zhong L; Zhang Y; Li M; Song Y; Liu D; Yang X; Yang D; Qu H; Lai L; Wang Q; Chen Z
Aging (Albany NY); 2020 Dec; 12(23):24394-24423. PubMed ID: 33260160
[TBL] [Abstract][Full Text] [Related]
11. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K
Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065
[TBL] [Abstract][Full Text] [Related]
12. Skp1-Cullin-F-box (SCF)-type ubiquitin ligase FBXW7 negatively regulates spermatogonial stem cell self-renewal.
Kanatsu-Shinohara M; Onoyama I; Nakayama KI; Shinohara T
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8826-31. PubMed ID: 24879440
[TBL] [Abstract][Full Text] [Related]
13. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
14. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF
Bajpai S; Jin HR; Mucha B; Diehl JA
Cancer Biol Ther; 2022 Dec; 23(1):348-357. PubMed ID: 35438057
[TBL] [Abstract][Full Text] [Related]
16. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation.
Meyer AE; Furumo Q; Stelloh C; Minella AC; Rao S
Neoplasia; 2020 Nov; 22(11):644-658. PubMed ID: 33070870
[TBL] [Abstract][Full Text] [Related]
17. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
[TBL] [Abstract][Full Text] [Related]
18. NRG1 regulates Fra-1 transcription and metastasis of triple-negative breast cancer cells via the c-Myc ubiquitination as manipulated by ERK1/2-mediated Fbxw7 phosphorylation.
Shu L; Chen A; Li L; Yao L; He Y; Xu J; Gu W; Li Q; Wang K; Zhang T; Liu G
Oncogene; 2022 Feb; 41(6):907-919. PubMed ID: 34992218
[TBL] [Abstract][Full Text] [Related]
19. DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein.
An J; Yang DY; Xu QZ; Zhang SM; Huo YY; Shang ZF; Wang Y; Wu DC; Zhou PK
Mol Cancer; 2008 Apr; 7():32. PubMed ID: 18426604
[TBL] [Abstract][Full Text] [Related]
20. Increased efficiency in the generation of induced pluripotent stem cells by Fbxw7 ablation.
Okita Y; Matsumoto A; Yumimoto K; Isoshita R; Nakayama KI
Genes Cells; 2012 Sep; 17(9):768-77. PubMed ID: 22897623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]